for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Vaccine blood clot concerns tap into difficulties around rare but real probabilities
Requiring digital proof of jabs could revive the economy but undermine equity and privacy